The pathological significance of MAD2L1 in breast cancer [52]; the metastasis promotion of PITPNC1 by melanoma, breast cancer, and colon cancer cells [53]; and the suppression of breast tumors by RIN1 [54] have also been reported. This evidence concerns the gene MAD2L1 and melanoma.